SAM.gov Experiencing Unexpected Outage and Generating Mistaken Emails as of March 8, 2023
Client Alert | 11 min read | 03.08.23
As of the morning of March 8, 2023, SAM.gov is experiencing an unexpected outage and the system also appears to be generating false emails. Until this issue is resolved, companies and administrators should consider refraining from clicking on any links or email addresses within any SAM.gov email received until the system is confirmed as fully operational.
At this time, the Federal Service Desk website has confirmed both the outage and mistaken emails:
The emails described above appear to have at least in some instances identified various registration changes made by a foreign email address to one of the recipient’s SAM registration.
Updates on the status of the SAM email and outage issues will be provided through the Federal Service Desk.
Contacts
Insights
Client Alert | 4 min read | 01.07.26
On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026.
Client Alert | 3 min read | 01.07.26
CMMC for AI? Defense Policy Law Imposes AI Security Framework and Requirements on Contractors
Client Alert | 3 min read | 01.07.26
New Year, Same CIPA Uncertainty – When Will the Appellate Courts Enter the Chat?
Client Alert | 11 min read | 01.07.26
